Both charts look good. DNDN better right now.
AGEN had a bullish cross of the 13 and 36-day MAs at the first of the year. That situation is still intact. I think AGEN pops to the upside soon, regardless of what happens on the PR front.
Because of analyst upgrade who thinks they've turned the corner.
Why aren't we going up? last i checked we had no revenue, so why would we? Do you think we should just because other biotechs with no revenue have a higher mkt cap? Quit thinking that way and wait for mage-3a results, if good, our PPS will pop big time, until then don't expect it to move. You want big money to move in only to have GSK Mage-3a not meet it's endpoint? PATIENCE. The rest of our pipeline is not that mature, more mature towards year end. If mage-3a meets it's endpoints we could easily have a 1 billion mkt cap valuation, herpes zoster would move this higher and stellar PII HerpV results even higher.
So big money only comes in once the future is certain?! How do they make money then? Once things are known the move is already over and it tops out. When do we get Mage 3a results? Do you expect the big money to buy in all at once causing the alleged pop? I would think big money is smart money and smart money gets in little by little over long periods of time then they dump big to get out later when the prices are high. AGEN has revenue from royalties but its just that the costs right now surpass the income so the company is losing money every quarter but which small cap speculative biotechs aren't?